1,1-dichloro-2,3-diphenyl-2-(4-methoxyphenyl)cyclopropane has been researched along with Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jain, PT; Magarian, RA; Pento, JT | 1 |
| Abidi, SM; Dmytryk, JJ; Howard, EW; Pento, JT | 1 |
2 other study(ies) available for 1,1-dichloro-2,3-diphenyl-2-(4-methoxyphenyl)cyclopropane and Breast Cancer
| Article | Year |
|---|---|
The influence of a novel cyclopropyl antiestrogen (compound 7a) on human breast cancer cells in culture.
Topics: Breast Neoplasms; Cell Division; Estradiol; Estrogen Antagonists; Female; Humans; Lung Neoplasms; Microscopy, Electron, Scanning; Microvilli; Protein Binding; Tamoxifen; Tumor Cells, Cultured | 1993 |
The influence of antiestrogens on the release of plasminogen activator (uPA) by MDA-MB-231 and MCF-7 breast cancer cells.
Topics: Breast Neoplasms; Estradiol; Estrogen Antagonists; Female; Fibronectins; Fulvestrant; Humans; Neoplasm Invasiveness; Tamoxifen; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 1998 |